3Farag SS,VanDeusen JB,Fehniger TA,et al.Biology and clinical impact of human nature killer cells[J].Int J Hematol,2003,78(1):7-17.
4Kang TH,Mao CP,He L,et al.Tumor-targeted delivery of IL-2 by NKG2D leads to accumulation of antigen-specific CD8 T cells in the tumor loci and enhanced anti-tumor effects[J].PLoS One,2012,7(4):e35141.
5Weiss JM,Ridnour LA,Back T,et al.Macrophage-dependent nitric oxide expression regulates tumor cell detachment and metastasis after IL-2/anti-CD40 immunotherapy[J].J Exp Med,2010,207(11):2455-2467.
6Brunasso AM,Puntoni M,Gulia A,et al.Safety of anti-tumour necrosis factor agents in patients with chronic hepatitis C infection:a systematic review[J].Rheumatology,2011,50(9):1700-1711.
7Shin EC,Ahn JM,Kim CH,et al.IFN-gamma induces cell death in human hepatoma cells through a TRAIL/death receptor-mediated apoptotic pathway[J].Int J Cancer,2001,93(2):262-268.
8Maynard CL,Weaver CT.Diversity in the contribution of intedeukin-10 to T-cell-mediated immune regulation[J].Immunol Rev,2008,(226):219-233.
9Zeng L,O'Connor C,Zhang J,et al.IL-10 promotes resistance to apoptosis and metastatic potential in lung tumor cell lines[J].Cytokine,2010,49(3):294-302.
